What’s the Buzz?! Empowering Health Innovation with BLUE KNIGHT™

Feb

What’s the Buzz?! Empowering Health Innovation with BLUE KNIGHT™ Over

Wed, 05th Feb 2025
30m
Online

Webinars

Description

In our next “What’s the Buzz?!,” we are thrilled to welcome Angela Specht, Global Head of BARDA Alliance for Johnson & Johnson Innovation. Angela will share the vision behind BLUE KNIGHT™, a collaboration between JLABS and the Biomedical Advanced Research and Development Authority (BARDA), and the exciting opportunities it presents for companies driving innovations in health security. She’ll also discuss the local impact of the BLUE KNIGHT™ hub at JLABS DC and what she’s most excited about for 2025.

Register for the event on LinkedIn: https://www.linkedin.com/events/what-sthebuzz-empoweringhealthi7289761092870832129/theater/

About Angela Specht
Angela Specht is the Global Head, BARDA Alliance for Johnson & Johnson Innovation. In this role, Angela leads BLUE KNIGHT™, a joint initiative between JLABS and the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response in the U.S. Department of Health and Human Services. BLUE KNIGHT™ aims to stimulate the innovation and incubation of science and technologies that may improve health security and response in areas of mutual areas of interest for BARDA and Johnson & Johnson. Angela leads the strategic direction, alliance management, and oversight of all operational activities related to the collaboration with BARDA, including managing the sourcing and selection of high potential companies for JLABS locations and developing global programming.

Angela is an experienced and passionate pharmaceutical executive with 20 years of experience in the health care industry. In her previous role as Sr. Director of Enterprise Innovation at Johnson & Johnson Development Corp (JJDC), she developed collaborations and business models that accelerate cross-sector innovation. Prior to her role with JJDC, Angela led the Johnson & Johnson Global Public Health Vaccine Access Strategy team, enabling access to the company’s innovative vaccine portfolio for the 4 billion people living in lower income markets.

She has also served as the strategy and finance leader on the Global Public Health Leadership Team, implementing the globally recognized global health structure within Johnson & Johnson and serving as co-chair of the Johnson & Johnson Enterprise Governance Council, where she leveraged her experience working with external stakeholders to shape the enterprise sustainability strategy and goals. Prior to joining Johnson & Johnson Global Public Health, Angela held various leadership roles across finance and strategy within the Johnson & Johnson pharmaceutical sector. Angela also serves on the finance committee of the StopTB Partnership.

Angela earned an MBA from the Wharton School of Business and earned her bachelor’s degree in Accounting from The Pennsylvania State University.

Sponsored by CRB.

The Event is Over

Select Tickets

Free

Total Price : $ 0